Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Total Liabilities Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual total liabilities in 2021 was 67.62 Million USD , down -80.41% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly total liabilities in 2022 Q2 was 62 Million USD , down -7.29% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported annual total liabilities of 345.18 Million USD in 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported quarterly total liabilities of 66.87 Million USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported quarterly total liabilities of 67.62 Million USD for 2021 FY, down -80.41% from previous quarter.

Annual Total Liabilities Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Historical Annual Total Liabilities of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Total Liabilities Total Liabilities Growth
2021 67.62 Million USD -80.41%
2020 345.18 Million USD 0.0%

Peer Total Liabilities Comparison of Clarus Therapeutics Holdings, Inc.

Name Total Liabilities Total Liabilities Difference
AstraZeneca PLC 61.86 Billion USD 99.891%
Bristol-Myers Squibb Company PFD CONV 2 65.67 Billion USD 99.897%
CSPC Pharmaceutical Group Limited 1.53 Billion USD 95.608%
Novartis AG 53.19 Billion USD 99.873%
PT Kalbe Farma Tbk. 255.94 Million USD 73.577%